Homebusiness News

    US FDA inspection at Jubilant Pharmova plant to focus on remediation of warning letter

    business | IST

    US FDA inspection at Jubilant Pharmova plant to focus on remediation of warning letter

    Mini

    The US FDA inspection at the Jubilant Pharmova's Roorkee plant is focused on remediation undertaken by the company on account of the warning letter issued to it in March 2019.

    The US FDA inspection at the Jubilant Pharmova's Roorkee plant is focused on remediation undertaken by the company on account of the warning letter issued to it in March 2019.
    This particular plant was inspected in August 2018 after which they received an official action indicated in December 2018 and then a warning letter in March 2019.
    Watch accompanying video of CNBC-TV18’s Ekta Batra for more details.
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    next story

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng